Table 2.

Results for secondary outcome measures

Outcome measure	IV opioid PCA (n = 20)	Liposome bupivacaine-based multimodal analgesia (n = 23)	P-value
Number of patients experiencing ORAEs	1	2
Median (range) time to first opioid use, hours	0.7 (0.3–3.6)	1.1 (0.3–71.0)	0.035a
Proportion of patients who reported being extremely satisfied with postsurgical pain treatment, %	40	48	0.752b
Proportion of patients who made unplanned visits with a health care provider after surgery, %	10	17	1.0c
Proportion of patients who made contact with health care provider to discuss recovery after surgery, %	25	9	0.11c

Notes:

^aDerived from log-rank test

^bderived from Mann–Whitney U-test

^cderived from Fisher’s exact test.

Abbreviations: IV, intravenous; n, number; ORAEs, opioid-related adverse events; PCA, patient-controlled analgesia.